Janssen’s Ebola Vaccine Added To Fight Against African Outbreak
People at risk of contracting the Ebola virus in the latest outbreak in the Democractic Republic of Congo are to have another vaccination option in the form of Janssen’s experimental prime-boost vaccine regimen, Ad26.ZEBOV/MVA-BN.
You may also be interested in...
The pharma major is providing its adjuvant system, designed to enhance the body’s immune response, to help the Coalition for Epidemic Preparedness Innovations' efforts to accelerate the creation of a vaccine for the coronavirus strain that broke out in China and has spread to 24 countries.
Merck Sharp & Dohme will begin manufacturing licensed doses of Ervebo in Germany and will continue to send investigational vaccine doses to Democratic Republic of Congo.
The European Medicines Agency has received 11 new marketing authorization applications, including three for orphan products from Vertex, MYR Pharmaceuticals and AstraZeneca.